Tauopathies are neurodegenerative diseases characterised by the build-up in the brain of tau protein ‘aggregates’ within nerve cells. These include forms of dementia, Pick's disease and ...

Taking longer to drift into the dreaming phase – known as rapid eye movement (REM) sleep – could be an early sign of ...

Tauopathies are neurodegenerative diseases characterised by the build-up in the brain of tau protein 'aggregates' within ...

These assays have previously focused on measuring individual proteins linked to Alzheimer’s disease, but the latest ... research shows that such tests can also pick up longitudinal changes ...

A study has revealed that one specific type of exercise can dramatically reduce the risk of developing Alzheimer's disease by ...

The Swiss pharma group is paying $120 million upfront for exclusive global rights to UCB0107, an anti-tau antibody that is in a phase 1 trial in another disease ... Tau is a protein that ...

Investors in TauRx Pharma have exercised warrants worth around $119 million, adding to the biotech's financial resources as it prepares regulatory filings for tau-targeting Alzheimer's drug ...

(NASDAQ: INM) ("InMed" or the "Company"), a pharmaceutical company focused on developing a pipeline of proprietary small molecule drug candidates for diseases ... plaques and tau protein tangles." ...

LATE is a prevalent condition in late life and can contribute to memory loss and cognitive decline, according to report co-author Rebecca M. Edelmayer, Ph.D., Alzheimer’s Association vice president of ...